We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth (UNH) Reports Q2 Earnings: What Key Metrics Have to Say
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) reported $98.86 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 6.4%. EPS of $6.80 for the same period compares to $6.14 a year ago.
The reported revenue represents a surprise of +0.15% over the Zacks Consensus Estimate of $98.71 billion. With the consensus EPS estimate being $6.65, the EPS surprise was +2.26%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Operating Statistics - Medical Care Ratio: 85.1% compared to the 84.4% average estimate based on eight analysts.
Customers - UnitedHealthcare - Total Commercial: 29,570 thousand versus 29,083.36 thousand estimated by five analysts on average.
Customers - UnitedHealthcare - Commercial- Risk-based: 8,735 thousand compared to the 8,482.2 thousand average estimate based on five analysts.
Customers - UnitedHealthcare - Commercial- Fee-based: 20,835 thousand compared to the 20,561.16 thousand average estimate based on five analysts.
Revenues- Investment and other income: $997 million compared to the $1.05 billion average estimate based on nine analysts. The reported number represents a change of -10.6% year over year.
Revenues- Products: $12.21 billion versus $11.67 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +14.7% change.
Revenues- Services: $8.75 billion versus $9.25 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +1% change.
Revenues- Premiums: $76.90 billion versus the nine-analyst average estimate of $76.90 billion. The reported number represents a year-over-year change of +6.1%.
Revenues- Optum Insight: $4.54 billion versus $4.87 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -2.8% change.
Revenues- Optum Rx: $32.42 billion versus the six-analyst average estimate of $31.40 billion. The reported number represents a year-over-year change of +13.2%.
Revenues- Optum Health: $27.05 billion versus $27.46 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +13.1% change.
Revenues- UnitedHealthcare: $73.87 billion versus the six-analyst average estimate of $73.69 billion. The reported number represents a year-over-year change of +5.2%.
Shares of UnitedHealth have returned +5.3% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth (UNH) Reports Q2 Earnings: What Key Metrics Have to Say
UnitedHealth Group (UNH - Free Report) reported $98.86 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 6.4%. EPS of $6.80 for the same period compares to $6.14 a year ago.
The reported revenue represents a surprise of +0.15% over the Zacks Consensus Estimate of $98.71 billion. With the consensus EPS estimate being $6.65, the EPS surprise was +2.26%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Operating Statistics - Medical Care Ratio: 85.1% compared to the 84.4% average estimate based on eight analysts.
- Customers - UnitedHealthcare - Total Commercial: 29,570 thousand versus 29,083.36 thousand estimated by five analysts on average.
- Customers - UnitedHealthcare - Commercial- Risk-based: 8,735 thousand compared to the 8,482.2 thousand average estimate based on five analysts.
- Customers - UnitedHealthcare - Commercial- Fee-based: 20,835 thousand compared to the 20,561.16 thousand average estimate based on five analysts.
- Revenues- Investment and other income: $997 million compared to the $1.05 billion average estimate based on nine analysts. The reported number represents a change of -10.6% year over year.
- Revenues- Products: $12.21 billion versus $11.67 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +14.7% change.
- Revenues- Services: $8.75 billion versus $9.25 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +1% change.
- Revenues- Premiums: $76.90 billion versus the nine-analyst average estimate of $76.90 billion. The reported number represents a year-over-year change of +6.1%.
- Revenues- Optum Insight: $4.54 billion versus $4.87 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -2.8% change.
- Revenues- Optum Rx: $32.42 billion versus the six-analyst average estimate of $31.40 billion. The reported number represents a year-over-year change of +13.2%.
- Revenues- Optum Health: $27.05 billion versus $27.46 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +13.1% change.
- Revenues- UnitedHealthcare: $73.87 billion versus the six-analyst average estimate of $73.69 billion. The reported number represents a year-over-year change of +5.2%.
View all Key Company Metrics for UnitedHealth here>>>Shares of UnitedHealth have returned +5.3% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.